Stock listing

Dusseldorf:RDDA Dr. Reddy's Laboratories Ltd. Aktie

German listing (Dusseldorf) of Dr. Reddy's Laboratories Ltd. · home listing NSE:DRREDDY

Follow Dr. Reddy's Laboratories Ltd. into a list and get an email when it puts out news.

Home listing price · NSE:DRREDDY

₹1,233.00 INR +14.20 (+1.2%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:DRREDDY

Since Jul 6, 2026 -9.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
₹1,214.10 – ₹1,233.00 INROct 16, 2026
Volume
1.26M sharesOct 16, 2026
Market value
₹1.03T INRAt the close on Oct 16, 2026 · price × 833.0M shares outstanding
Dr. Reddy's Laboratories Ltd. logo
Ticker
Dusseldorf:RDDA
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Dusseldorf
Currency
EUR

What changed lately

Calls

Upcoming

  • Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call

    Fri, Oct 23, 2026 · 10:00 AM ET

    Register

Replays

  • Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call

    Wed, Jul 22, 2026 · 10:00 AM ET

    Watch Transcript

  • Dr. Reddy's Laboratories (NSE:DRREDDY) Q4 2026 Earnings Call

    Tue, May 12, 2026 · 10:00 AM ET

    Watch Transcript

  • Dr. Reddy's Laboratories (NSE:DRREDDY) Q3 2026 Earnings Call

    Wed, Jan 21, 2026 · 7:30 PM ET

    Watch Transcript

Latest news

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 07, 2026, titled "Intimation of Earnings call".

Oct 7, 2026

Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States

Aug 4, 2026

Dr. Reddy's Laboratories Ltd. Press Release Aug 01 2026

Aug 1, 2026

Dr. Reddy's Laboratories Ltd. Press Release Jul 23 2026

Jul 22, 2026

Dr. Reddy's Laboratories Ltd. Press Release Jul 13 2026

Jul 13, 2026

Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F

Jun 29, 2026

Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States

Jun 13, 2026

Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F)

May 29, 2026

Press Release May 28 2026

May 28, 2026

Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada

May 16, 2026

All Dr. Reddy's Laboratories Ltd. news

Decks

Dr. Reddy's Laboratories Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
34 in the last 12 months · 167 in all · newest Oct 7, 2026 · oldest 2020
Calls
24 calls with a replay · 24 with a transcript · latest Jul 22, 2026
Decks
21 decks · latest Jul 22, 2026

Where Dr. Reddy's Laboratories Ltd. is listed

ListingExchangeCountryCurrency
NSE:DRREDDY · Home listingNSEIndiaINR
NYSE:RDYNYSEUnited StatesUSD
BSE:DRREDDYBSEIndiaINR
gettex:RDDAgettexGermanyEUR
B3:R1DY34B3BrazilBRL
BOATS:RDYBOATSUnited StatesUSD
Frankfurt:RDDAFrankfurtGermanyEUR
Lang & Schwarz:659157Lang & SchwarzGermanyEUR
LS Exchange:659157LS ExchangeGermanyEUR
Stuttgart:RDDAStuttgartGermanyEUR
Munich:RDDAMunichGermanyEUR
Dusseldorf:RDDA · This pageDusseldorfGermanyEUR

Log in to ask 6ix AI your own questions about Dr. Reddy's Laboratories Ltd.